Peptide laws in the United Arab Emirates
Last updated: October 3, 2026 · 6 min read · By the Grey Peptides Editorial Board
- In 2026 the UAE's drug regulator acted against 71 sources selling unapproved peptide products for weight loss and referred 14 influencers.
- The regulator stated that retatrutide is still under clinical investigation and is not approved for marketing or medical use in the UAE.
- Personal import of medicines is capped: three months' supply for controlled medicines, six months for prescription-only medicines.
- GLP-1 medicines are prescription-only, dispensed by licensed pharmacies against a prescription from a licensed doctor.
How the UAE regulates medicines
Medicines in the UAE are regulated federally. The Emirates Drug Establishment is the drug regulator, the Ministry of Health and Prevention (MOHAP) runs health services including the personal medicine import permit, and the emirate-level authorities in Dubai and Abu Dhabi license practitioners and facilities. The governing legislation is Federal Decree-Law No. 38 of 2024 on medical products, pharmacists and pharmaceutical establishments 1.
Two features matter for peptides. A product must be registered before it can be marketed, and medicines are sorted into classes, including narcotic and controlled, semi-controlled and prescription-only, that decide what may be brought into the country and on what paperwork 2.
The 2026 action against unapproved peptides
In mid-2026 the Emirates Drug Establishment announced regulatory measures against 71 sources found to have marketed, promoted or sold products containing peptides that are not approved for use and were being promoted as weight-loss and slimming solutions, according to reporting of the regulator's statements to the Arabic daily Al Etihad 3. The action covered 14 registered facilities cited for regulatory violations, and 14 social-media influencers were referred to the National Media Authority 3.
The regulator named one compound directly. Retatrutide, promoted on social media and online marketplaces as a weight-loss injection, remains under clinical investigation and has not been approved by the Emirates Drug Establishment for marketing or medical use in the UAE 3. Our retatrutide entry records its trial status, and our guide to what testing has found covers the analyses of material sold under that name.
This is a stronger position than most regulators have stated publicly: not a general warning about unapproved medicines, but enforcement against named sellers of peptide products together with a statement that a specific investigational peptide is not approved 3.
Approved GLP-1 medicines are prescription-only
GLP-1 medicines sold in the UAE, including semaglutide and tirzepatide products, are prescription-only and may be dispensed by a licensed pharmacy only against a prescription from a doctor licensed by one of the health authorities 4. Oral semaglutide for weight management was approved by the Emirates Drug Establishment in June 2026, and an oral GLP-1 from another manufacturer was approved in April 2026 4.
The clinical criteria reported for a GLP-1 prescription follow the usual thresholds: a body mass index above 30, or 27 with a weight-related condition 4. Anything sold as a GLP-1 product outside that route, in particular online or through social media, is outside the system the regulator is enforcing 3.
Bringing medicines into the UAE
MOHAP operates a Permit to Import Medicines for Personal Use. As published in its service description, prior approval is optional for travellers visiting the country, who may carry narcotic and psychotropic (controlled) medicines within a quantity not exceeding the patient's need for a maximum of three months; without prior approval, travellers must declare those medicines on arrival at the country's ports with the prescription and medical report; transit travellers who do not leave the ports need no prior approval but are advised to carry the prescription 2.
The published service material sets quantity limits by class: a maximum of three months' supply for narcotics and controlled medicines, and six months for prescription-only medicines 2. Documents must be recent and issued by the treating facility, and for narcotic or psychotropic medicines authenticated by the health authority of the country of treatment 2. MOHAP's site refused our requests and disallows automated access, so these terms are taken from its published service text and service documents as reproduced in search results and reporting, and are described as reported rather than quoted 2.
None of this creates a route for unregistered products. A permit is for a medicine a patient has been prescribed; a research peptide has no prescription, no registration and no class.
Research peptides
Research peptides such as BPC-157, TB-500 and retatrutide are not approved medicines in the UAE 5 3. The 2026 enforcement shows the regulator treating their promotion and sale as a violation rather than a grey area, and the referral of influencers to the media authority extends that to promotion as well as supply 3.
For anyone in the UAE, the risk is not only regulatory. Products bought from unlicensed online sellers cannot be verified for authenticity, quality or storage, which is the regulator's own stated concern 3, and our manufacturing guide covers what laboratory analyses of such material have found.
Sport
Athletes in the UAE are subject to the WADA Prohibited List through the national anti-doping organisation. BPC-157 is caught by the S0 catch-all, and growth hormone secretagogues and releasing peptides are named under S2.2.4; GLP-1 receptor agonists are not prohibited 5. Our WADA hub lists each peptide and section.
The UAE in context
The UAE's 2026 action is the enforcement end of a pattern we track elsewhere: Thailand reclassified injectable GLP-1 medicines as specially controlled from September 2026, China closed online retail and online prescribing of higher-risk injectables in May 2026, and Japan's ministry wrote to manufacturers about off-label cosmetic use. Our Thailand page, China page and legal overview set those out.
Questions to check
- Is the product registered in the UAE, and is the seller a licensed pharmacy or facility?
- Is the prescription from a doctor licensed by one of the UAE health authorities?
- Does my medicine fall in a controlled or semi-controlled class needing a MOHAP permit?
- Am I within the published quantity limits, with the right documents?
- Am I subject to anti-doping rules?
The bottom line
The UAE pairs a strict import system with active enforcement. In 2026 its drug regulator acted against 71 sources selling unapproved peptide products for weight loss, referred 14 influencers to the media authority, and said plainly that retatrutide is not approved. Approved GLP-1 medicines are prescription-only, personal imports are capped by class, and research peptides sit outside the system entirely.
Frequently asked questions
Are peptides legal in the UAE?
Approved peptide medicines are prescription-only. Research peptides are not approved, and in 2026 the drug regulator acted against 71 sources selling unapproved peptide products.
Is retatrutide approved in the UAE?
No. The Emirates Drug Establishment stated it remains under clinical investigation and is not approved for marketing or medical use.
Do I need a permit to bring medicines into the UAE?
A MOHAP permit is for narcotic, controlled and semi-controlled medicines. Prescription-only medicines are carried with the prescription, within published quantity limits.
How much medicine can I bring into the UAE?
As published by MOHAP, up to three months' supply of narcotic and controlled medicines and up to six months of prescription-only medicines.
Can I buy Ozempic without a prescription in Dubai?
No. GLP-1 medicines are prescription-only and must be dispensed by a licensed pharmacy against a prescription from a licensed doctor.
Related on Grey Peptides
Sources
- Government of Dubai portal, controlled medicines page, naming Federal Decree-Law No. (38) of 2024 governing medical products, pharmacists and pharmaceutical establishments, and MOHAP's controlled medicines list. Read October 3, 2026.
- Ministry of Health and Prevention (UAE). Issue of Permit to Import Medicines for Personal Use: service description and service documents (three-month limit for narcotics and controlled medicines, six months for prescription-only medicines, optional prior approval for travellers, declaration on arrival, transit travellers). mohap.gov.ae refused our requests (HTTP 503) and disallows automated access; text as published in the service material and reproduced in Gulf News and Emirates 24|7 reporting. Read October 3, 2026.
- Emirates Drug Establishment, regulatory measures against 71 sources marketing or selling unapproved peptide products for weight loss, 14 facilities cited and 14 influencers referred to the National Media Authority, and its statement that retatrutide is not approved: statements to Al Etihad as reported by Gulf News and Khaleej Times, 2026. Read October 3, 2026.
- UAE reporting on prescription-only status and approvals of GLP-1 medicines, including the Emirates Drug Establishment's June 2026 approval of oral semaglutide and the April 2026 approval of an oral GLP-1, and the BMI criteria applied (The National; Gulf News). Read October 3, 2026.
- Grey Peptides encyclopedia and WADA hub: no approval recorded for BPC-157, TB-500 or retatrutide in any jurisdiction we track; WADA sections S0 and S2.2.4; GLP-1 receptor agonists not prohibited. Read October 3, 2026.
Educational information, not medical advice. Each dose in this guide names its source, an approved label or a published study. None is a recommendation for you. An unapproved compound has no established safe or effective human dose, and products sold for “research use only” are not made or tested for people. Talk to a doctor before acting on anything on this site, including before you start, stop or change any medicine or dose.
New guides and rule changes, by email
One short email when a peptide's legal status moves — an FDA or PCAC decision, a WADA list change, an enforcement action — plus new guides and tools. At most one a week, and none when nothing changes. The newsletter has not started sending yet: your first email will be its first issue.
We keep your email address and the page you signed up from, nothing else. How it works · Privacy · RSS instead